These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 7804729)

  • 1. Haemostatic function and arterial disease.
    Meade TW
    Br Med Bull; 1994 Oct; 50(4):755-75. PubMed ID: 7804729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombosis and cardiovascular disease.
    Meade TW
    Ann Epidemiol; 1992 Jul; 2(4):353-64. PubMed ID: 1342286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma fibrinogen and factor VII as risk factors for cardiovascular disease.
    Kelleher CC
    Eur J Epidemiol; 1992 May; 8 Suppl 1():79-82. PubMed ID: 1505657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinogen in ischaemic heart disease.
    Meade TW
    Eur Heart J; 1995 Mar; 16 Suppl A():31-4; discussion 34-5. PubMed ID: 7796828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity, haemostasis and the fibrinolytic system.
    Mertens I; Van Gaal LF
    Obes Rev; 2002 May; 3(2):85-101. PubMed ID: 12120424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemostatic factors and prediction of ischaemic heart disease and stroke in claudicants.
    Smith FB; Rumley A; Lee AJ; Leng GC; Fowkes FG; Lowe GD
    Br J Haematol; 1998 Mar; 100(4):758-63. PubMed ID: 9531345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Besides fibrinogen, are haemostatic, coagulation and/or fibrinolytic parameters predictors or markers of the risk of cardiovascular events?].
    Drouet L; Bal dit Sollier C
    Therapie; 2005; 60(2):137-47. PubMed ID: 15969316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercoagulability and ischaemic heart disease.
    Meade TW
    Blood Rev; 1987 Mar; 1(1):2-8. PubMed ID: 3332083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An international and interregional comparison of haemostatic variables in the study of ischaemic heart disease. Report of a working group.
    Meade TW; Stirling Y; Thompson SG; Vickers MV; Woolf L; Ajdukiewicz AB; Stewart G; Davidson JF; Walker ID; Douglas AS
    Int J Epidemiol; 1986 Sep; 15(3):331-6. PubMed ID: 3095254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.
    Meade TW; Mellows S; Brozovic M; Miller GJ; Chakrabarti RR; North WR; Haines AP; Stirling Y; Imeson JD; Thompson SG
    Lancet; 1986 Sep; 2(8506):533-7. PubMed ID: 2875280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemostatic/inflammatory markers predict 10-year risk of IHD at least as well as lipids: the Caerphilly collaborative studies.
    Yarnell JW; Patterson CC; Sweetnam PM; Lowe GD
    Eur Heart J; 2004 Jun; 25(12):1049-56. PubMed ID: 15191776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HEMOSTATIC MECHANISM IN EXTRACORPOREAL CIRCULATION.
    MARIN HM
    Arch Surg; 1964 Jun; 88():988-98. PubMed ID: 14132005
    [No Abstract]   [Full Text] [Related]  

  • 13. Epidemiology of thrombotic-hemostatic factors and their associations with cardiovascular disease.
    Pearson TA; LaCava J; Weil HF
    Am J Clin Nutr; 1997 May; 65(5 Suppl):1674S-1682S. PubMed ID: 9129509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HEMOSTASIS IN DENTISTRY, WITH SPECIAL REFERENCE TO HEMOCOAGULATION. I. THE BASIC THEORY OF HEMOSTASIS.
    SPOUGE JD
    Oral Surg Oral Med Oral Pathol; 1964 Oct; 18():445-54. PubMed ID: 14198078
    [No Abstract]   [Full Text] [Related]  

  • 15. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemostatic function, arterial disease and the prevention of arterial thrombosis.
    Meade TW
    Baillieres Clin Haematol; 1994 Sep; 7(3):733-55. PubMed ID: 7841608
    [No Abstract]   [Full Text] [Related]  

  • 17. Haemostatic risk factors for cardiovascular diseases.
    Koenig W
    Eur Heart J; 1998 Apr; 19 Suppl C():C39-43. PubMed ID: 9597424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factor VIII, ABO blood group and the incidence of ischaemic heart disease.
    Meade TW; Cooper JA; Stirling Y; Howarth DJ; Ruddock V; Miller GJ
    Br J Haematol; 1994 Nov; 88(3):601-7. PubMed ID: 7819072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disorders of Fibrinogen and Fibrinolysis.
    May JE; Wolberg AS; Lim MY
    Hematol Oncol Clin North Am; 2021 Dec; 35(6):1197-1217. PubMed ID: 34404562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor-VII activity and ischaemic heart disease: fatal and non-fatal events.
    Ruddock V; Meade TW
    QJM; 1994 Jul; 87(7):403-6. PubMed ID: 7922291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.